Biomarker Reference · Detoxification

What does the Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) test measure?

Q: What is the reference range for Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants)?

The standard reference range for Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) is Genotype result reported per variant; no numeric reference range applies # REVIEWER FLAG: Genotype result — reviewer to confirm the variants reported and bound interpretive claims.. Reference ranges vary by laboratory and assay platform — interpret in context of the issuing laboratory's stated range.

Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) (Detoxification) is a clinical biomarker used in genetic-testing assessment. Hepatic detoxification proceeds through Phase I (e.g. It is measured in 1 laboratory test on BiomarkersLabs.com.

Reference Range: Genotype result reported per variant; no numeric reference range applies # REVIEWER FLAG: Genotype result — reviewer to confirm the variants reported and bound interpretive claims.
Units: genotype
Measured In: 1 test
Category: Genetic Testing

Functional medicine optimalNot applicable — genotype result, not a measured value

What is Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants)?

Hepatic detoxification proceeds through Phase I (e.g. cytochrome P450 enzymes) and Phase II (e.g. glutathione-S-transferase, N-acetyltransferase) reactions that modify and conjugate endogenous and exogenous compounds for excretion. Variants in these genes can alter enzyme activity. The panel reports genotype at selected detoxification-related variants.

Why is Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) measured?

Detoxification genotypes are used in functional practice to inform lifestyle and nutritional guidance around oxidative load and exposure. Because enzyme activity is also strongly influenced by environment, diet, and other genes, genotype is interpreted as a contextual input rather than a definitive measure of detoxification capacity.

Reference ranges

Standard reference: Genotype result reported per variant; no numeric reference range applies # REVIEWER FLAG: Genotype result — reviewer to confirm the variants reported and bound interpretive claims.
Functional medicine optimal: Not applicable — genotype result, not a measured value
Units: genotype

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.

Tests that measure Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants)

1 test on BiomarkersLabs.com include this biomarker.

BML-GEN-001Comprehensive

3X4 Genetics Test with Blueprint Report

Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) reference range in this test: Genotype result reported per variant; no numeric reference range applies # REVIEWER FLAG: Genotype result — reviewer to confirm the variants reported and bound interpretive claims.

Related clinical conditions

Related Biomarkers

Frequently measured alongside

Methylation Pathway Gene Panel (e.g. MTHFR and related variants)Methylation1 test Inflammation Pathway Gene PanelInflammation1 test Oxidative Stress Pathway Gene Panel (e.g. SOD, antioxidant-defence variants)Oxidative Stress1 test Lipid Metabolism Gene Panel (e.g. APOE and related variants)Lipid Metabolism1 test Vitamin and Nutrient Metabolism Gene PanelNutrient Metabolism1 test Hormone Metabolism Gene PanelHormone Metabolism1 test Metabolic, Insulin and Glucose Pathway Gene PanelMetabolic1 test

Order tests measuring Detoxification Pathway Gene Panel (Phase I/II, e.g. CYP, GST, NAT variants) for your patients

Available exclusively to verified licensed healthcare practitioners. CLIA-certified laboratory results delivered to your secure portal.

Create Free Account